Cordyceps Sunshine Biotech Holdings RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Cordyceps Sunshine Biotech Holdings (RAJAF) Income from Continuing Operations (2021 - 2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) posted quarterly Income from Continuing Operations of 83430.0 for Q4 2023, up 326.15% year-over-year from 19577.49 in Q4 2022, and up 326.15% quarter-over-quarter from 36891.0 in Q4 2022.

Cordyceps Sunshine Biotech Holdings (RAJAF) Income from Continuing Operations (2021 - 2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 83430.0 for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Kraft Heinz 30.37 Bn 27.69 Bn 2.03 Bn -5.46 Bn
2 General Mills 21.49 Bn 21.03 Bn 1.60 Bn -1.99 Bn
3 Mccormick 14.93 Bn 14.60 Bn 778.20 Mn 156.70 Mn
4 Jbs 14.80 Bn 11.34 Bn 4.91 Bn -96.18 Mn
5 J M Smucker 13.21 Bn 13.15 Bn 862.10 Mn 388.10 Mn
6 Hormel Foods 13.14 Bn 12.28 Bn 518.51 Mn 157.38 Mn
7 Magnum Ice Cream 12.22 Bn 11.50 Bn - -
8 Darling Ingredients 10.40 Bn 10.24 Bn 503.37 Mn 389.27 Mn
9 Smithfield Foods 8.75 Bn 7.40 Bn 478.00 Mn 235.00 Mn
10 Cordyceps Sunshine Biotech Holdings 1.02 Bn 1.02 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 83,430.00
Dec 31, 2022 -36,891.00
Dec 31, 2021 -176,212.00